Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 08th Mar 2018 15:39

Friday 9 March 
SIGFull Year Results
InmarsatFull Year Results
GVC HoldingsFull Year Results
Monday 12 March 
ClarksonFull Year Results
Medica GroupFull Year Results
Hutchison China MeditechFull Year Results
Polymetal InternationalFull Year Results
Global Ports HoldingFull Year Results
Tuesday 13 March 
AntofagastaFull Year Results
TP ICAPFull Year Results
Cairn EnergyFull Year Results
BangoFull Year Results
Midwich GroupFull Year Results
Stadium GroupFull Year Results
Goals Soccer CentresFull Year Results
XLMediaFull Year Results
Fevertree DrinksFull Year Results
John MenziesFull Year Results
RestoreFull Year Results
Non-Standard FinanceFull Year Results
Seeing MachinesHalf Year Results
LMS CapitalFull Year Results
CrossriderFull Year Results
Surgical InnovationsFull Year Results
ApplegreenFull Year Results
ComputacenterFull Year Results
Close Brothers GroupFull Year Results
Gresham TechnologiesFull Year Results
ZotefoamsFull Year Results
Baillie Gifford Shin NipponFull Year Results
H&T GroupFull Year Results
French Connection GroupFull Year Results
Smart Matering SystemsFull Year Results
Wednesday 14 March 
PrudentialFull Year Results
DignityFull Year Results
Brooks MacdonaldHalf Year Results
WM Morrison SupermarketsFull Year Results
Balfour BeattyFull Year Results
Charles TaylorTrading Statement 
Burford CapitalFull Year Results
Hikma PharmaceuticalsFull Year Results
MarshallsFull Year Results
EMIS GroupFull Year Results
ForterraFull Year Results
Advanced Medical Solutions GroupFull Year Results
Safecharge InternationalFull Year Results
NorthamberHalf Year Results
Thursday 15 March 
Old MutualFull Year Results
Phoenix GroupFull Year Results
Cineworld GroupFull Year Results
Just GroupFull Year Results
Onesavings BankFull Year Results
SavillsFull Year Results
Kier GroupHalf Year Results
Spirax-Sarco EngineeringFull Year Results
Forbidden Technologies Full Year Results
Amryt PharmaTrading Statement 
  

More News
3 Jun 2020 11:52

UK TRADING UPDATE SUMMARY: Integumen Kicks Off Covid-19 Skin Trials

UK TRADING UPDATE SUMMARY: Integumen Kicks Off Covid-19 Skin Trials

Read more
11 May 2020 12:19

Amryt Pharma Cheers Strong 2019 And Beats Expectations So Far In 2020

Amryt Pharma Cheers Strong 2019 And Beats Expectations So Far In 2020

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
23 Mar 2020 19:01

Amryt Pharma Financially Strong, Revenue Rises More Double Digits

Amryt Pharma Financially Strong, Revenue Rises More Double Digits

Read more
19 Dec 2019 14:13

Amryt Pharma Shares Rise As It Cheers Aegerion Acquisition Synergies

Amryt Pharma Shares Rise As It Cheers Aegerion Acquisition Synergies

Read more
5 Nov 2019 11:09

Amryt Pharma upbeat on progress in first nine months of year

(Sharecast News) - Amryt Pharma updated the market on its trading update for the nine months ended 30 September on Tuesday, noting that it had completed the transaction to acquire Aegerion Pharmaceuticals on 24 September.

Read more
5 Nov 2019 10:23

Amryt Pharma Revenue Rises On Performance From Two New Assets

Amryt Pharma Revenue Rises On Performance From Two New Assets

Read more
1 Oct 2019 18:49

Amryt Pharma Skin Condition Drug Gets US FDA Fast Track Designation

Amryt Pharma Skin Condition Drug Gets US FDA Fast Track Designation

Read more
1 Oct 2019 15:08

Amryt gets FDA fast track for Oleogel-S10

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced on Tuesday that the US Food and Drug Administration (FDA) has designated the investigation of 'AP101' - Oleogel-S10 - for the treatment of epidermolysis bullosa (EB) as a 'Fast Track' development programme.

Read more
30 Sep 2019 18:49

Amryt Pharma Loss Widens On Aegerion Deal Costs; Lojuxta Revenue Rises

Amryt Pharma Loss Widens On Aegerion Deal Costs; Lojuxta Revenue Rises

Read more
25 Sep 2019 12:24

Amryt Pharma Completes Combination With Aegerion Pharmaceuticals

Amryt Pharma Completes Combination With Aegerion Pharmaceuticals

Read more
24 Sep 2019 15:00

Amryt Pharma Shares Temporarily Suspended On Aegerion Buy

Amryt Pharma Shares Temporarily Suspended On Aegerion Buy

Read more
21 May 2019 12:35

Amryt Pharma Agrees To All-Paper Acquisition Of Aegerion (ALLISS)

LONDON (Alliance News) - Amryt Pharma PLC on Tuesday said it has agreed the all-paper acquisition of Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics Inc, and intends to raise USD60

Read more
17 Apr 2019 11:17

Amryt Pharma Loss Narrows On Revenue From Cholesterol Drug Lojuxta

LONDON (Alliance News) - Amryt Pharma PLC on Wednesday said its annual loss narrowed as a result of increased revenue from its drug Lojuxta.The company's pretax loss shrank to EUR25.7

Read more
28 Feb 2019 14:39

Amryt gets approval to extend EASE trial to infants and children

(Sharecast News) - Orphan drug company Amryt Pharma updated the market on its phase 3 'EASE' trial for AP101 as a potential treatment for epidermolysis bullosa (EB) on Thursday, reporting that following an assessment by the trial's independent data monitoring committee, it could now enrol infants and children with EB between the ages of 21 days to four years in the trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.